Milestone Scientific (MLSS) Cash from Investing Activities (2010 - 2026)
Milestone Scientific (MLSS) posted Cash from Investing Activities of -$1632.0 for Q1 2026, up 47.63% sequentially from -$3116.0 in Q4 2025, and down 25.15% YoY from -$2180.5 in Q1 2025.
Milestone Scientific (MLSS) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Milestone Scientific has reported Cash from Investing Activities for 17 years, with the latest figure at -$1632.0 in Q1 2026.
- Quarterly Cash from Investing Activities fell 25.15% year-over-year to -$1632.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15452.0 (down 101.61% YoY) and the FY2025 annual result came in at -$15124.0, down 100.51% from the prior year.
- Cash from Investing Activities grew to -$1632.0 in Q1 2026 per MLSS's latest filing, from -$3116.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $2.4 million in Q2 2023 and troughed at -$4.4 million in Q1 2023.
- A 5-year average of -$2067.1 and a median of -$3528.0 in 2024 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 2881311.76% in 2023, down 12054.75% in 2023.
- Over 5 years, Cash from Investing Activities stood at -$4700.0 in 2022, then slumped by 10842.6% to -$514302.0 in 2023, then jumped by 99.31% to -$3528.0 in 2024, then grew by 11.68% to -$3116.0 in 2025, then soared by 47.63% to -$1632.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$1632.0, -$3116.0, and -$6232.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Milestone Scientific | 41.18 Mn | 38.57 Mn | 1.56 Mn | -1,632.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,632.00 |
| Mar 31, 2026 | -1,632.00 |
| Dec 31, 2025 | -3,116.00 |
| Dec 31, 2025 | -3,116.00 |
| Sep 30, 2025 | -6,232.00 |
| Sep 30, 2025 | -6,232.00 |
| Jun 30, 2025 | -4,472.00 |
| Jun 30, 2025 | -4,472.00 |
| Mar 31, 2025 | -1,304.00 |
| Mar 31, 2025 | -1,304.00 |
| Dec 31, 2024 | -3,528.00 |
| Dec 31, 2024 | -3,528.00 |
| Jun 30, 2024 | 965,514.00 |
| Jun 30, 2024 | 965,514.00 |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | -514,302.00 |
| Dec 31, 2023 | -514,302.00 |
| Sep 30, 2023 | -475,494.00 |
| Sep 30, 2023 | -475,494.00 |